BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials

Autor:	Kan Liu, Yan Huang, Yu Xu, Guoqiang Wang, Shangli Cai, Xu Zhang, Taoping Shi
Rok vydání:	2023
Předmět:	Cancer Research Oncology Immunology Immunology and Allergy
Zdroj:	Cancer Immunology, Immunotherapy.
ISSN:	1432-0851 0340-7004
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::54f40d1e7c1c383327500ae442bbd799 https://doi.org/10.1007/s00262-023-03424-4 Zobrazit plný text záznamu Full text from SpringerLink